UPDATE: Needham & Company Starts UiPath Inc. (PATH) at Buy May 17, 2021 05:39AM
UiPath Announces Closing of Initial Public Offering Apr 23, 2021 04:15PM
UiPath (PATH) IPO Opens 17% Higher Apr 21, 2021 12:44PM
UiPath Inc. (PATH) Prices 23.89M Share IPO at $56/Sh Apr 21, 2021 05:55AM
UiPath Announces Pricing of Initial Public Offering Apr 20, 2021 09:23PM

Jan 21, 2014 09:34AM Pre-Open Stock Movers 1/21: (HEB) (YRCW) (DOW) Higher; (AMRN) (PATH) (DB) Lower (more...)
Jan 8, 2014 09:32AM Pre-Open Stock Movers 1/8: (PATH) (FRX) (MU) Higher; (TCS) (JCP) (TWTR) Lower (more...)
Jan 22, 2013 09:47AM StreetInsider.com Pre-Open Movers 01/22: (ATNI) (BOX) (RIMM) Higher; (ARNA) (NUS) (FTNT) Lower (more...)
Mar 21, 2012 07:55AM Needham & Company Maintains a 'Hold' on NuPathe (PATH); Continues Marching Forward
Aug 16, 2011 07:46AM Needham & Company Maintains a 'Buy' on NuPathe (PATH); Zelrix Profile Continues to Grow Ahead of August FDA Action Date
Aug 3, 2011 11:03AM Morning Movers 08/03: (CBM) (SIMG) (FIX) (GNET) Higher; (CBR) (KFRC) (EXAM) (KRA) Lower
Sep 15, 2010 07:53AM Needham & Company Initiates Coverage on NuPathe (PATH) with a 'Buy'; Zelrix Poised To Emerge As Differentiated Treatment Option In Migraine
Aug 6, 2010 11:25AM NuPathe (PATH) IPO Trades Flat
Aug 6, 2010 10:50AM NuPathe (PATH) Sees IPO Price at $10/Share
Jul 21, 2010 02:38PM NuPathe (PATH) Sees IPO Price of $14 - $16/Share
May 14, 2010 01:37PM NuPathe Inc. (PATH) Files $86.25M IPO